Bio-Rad Laboratories BIO
NYSE BIO
$376.41 +12.15 (+3.34%)
At close: Aug 20, 2026 · 4:00 PM EDT

Bio-Rad Laboratories (BIO) Net Shares Issued and Repurchased (2019)

Bio-Rad Laboratories (BIO) posted quarterly Net Shares Issued and Repurchased of $3.8 million for Q1 2019.

Bio-Rad Laboratories (BIO) Net Shares Issued and Repurchased (2019) Analysis & Trends

Bio-Rad Laboratories (BIO) has reported Net Shares Issued and Repurchased for 1 consecutive years, with $3.8 million the latest figure, recorded in Q1 2019.

  • In Q1 2019, Net Shares Issued and Repurchased changed N/A year-over-year to $3.8 million; the TTM figure through Dec 2019 stood at $3.8 million (changed N/A YoY), while the FY2019 annual figure was $3.8 million, changed N/A from the prior year.
  • Net Shares Issued and Repurchased was little changed at $3.8 million in Q1 2019 per BIO's latest filing.
  • Across five years, Net Shares Issued and Repurchased topped out at $3.8 million in Q1 2019 and bottomed at $3.8 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -79.04 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2019 3.83 Mn
Mar 31, 2019 3.83 Mn